Biotech financing

Innovation capital raised by leading US regions, 2015
Los Angeles/Orange County
Mid-Atlantic
New England
New Jersey
New York State
San Diego
San Francisco Bay Area
14
Innovation capital raised (US$b)
12
10
8
6
4
2
Venture capital raised (US$m)
Source: EY, Capital IQ and VentureSource.
Size of bubbles shows relative number of financings per region. Innovation capital is the amount of equity capital raised
by companies with revenues of less than US$500 million.
Once again, biotech’s familiar geographic strongholds
topped the charts in innovation capital, with New England
(US$10.6 billion and 175 deals) maintaining its first place
position and adding some distance between itself and
the competition. In fact, the top four (and five of the top
six) financings went to companies located in Cambridge,
Massachusetts. San Francisco Bay area companies raised
US$6.5 billion across 142 deals. Looking at just venture capital
and IPO investment, New England companies raised US$4.3
billion, while Bay Area companies hauled in US$3.4 billion.
Beyond borders 2016 — Biotech financing
15